Nature CommunicationsGenomicsPeer-reviewed journal article
The genomic and epigenomic evolutionary history of papillary renal cell carcinomas
Bin ZhuiD, Maria Luana PoetaiD, Manuela CostantiniiD, Tongwu ZhangiD, Jianxin ShiiD, Steno Sentinelli, Zhao WeiiD, Vincenzo Pompeo, Maurizio CardelliiD, Boian S. AlexandroviD, Burçak OtluiD, Xing HuaiD, Kristine M. JonesiD, Seth A. BrodieiD, Malgorzata Ewa DabrowskaiD, Jorge R. Toro, Meredith YeageriD, Mingyi WangiD, Belynda D. HicksiD, Ludmil B. AlexandroviD, Kevin M. BrowniD, David C. WedgeiD, Stephen Jacob ChanockiD, Vito Michele FazioiD, Michele GallucciiD, Maria Teresa LandiiD
Abstract
Intratumor heterogeneity (ITH) and tumor evolution have been well described for clear cell renal cell carcinomas (ccRCC), but they are less studied for other kidney cancer subtypes. Here we investigate ITH and clonal evolution of papillary renal cell carcinoma (pRCC) and rarer kidney cancer subtypes, integrating whole-genome sequencing and DNA methylation data. In 29 tumors, up to 10 samples from the center to the periphery of each tumor, and metastatic samples in 2 cases, enable phylogenetic analysis of spatial features of clonal expansion, which shows congruent patterns of genomic and epigenomic evolution. In contrast to previous studies of ccRCC, in pRCC driver gene mutations and most arm-level somatic copy number alterations (SCNAs) are clonal. These findings suggest that a single biopsy would be sufficient to identify the important genetic drivers and targeting large-scale SCNAs may improve pRCC treatment, which is currently poor. While type 1 pRCC displays near absence of structural variants (SVs), the more aggressive type 2 pRCC and the rarer subtypes have numerous SVs, which should be pursued for prognostic significance.
- organism: human
- assay: whole-genome sequencing
- assay: DNA methylation
- research focus: variant calling
- approach: statistical model
- Citations
- 37
- FWCI
- 1.71
- Field percentile
- top 16%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Spatial distribution of private gene mutations in clear cell renal cell carcinoma
A. L. Moore, A. A. Batavia, … N. Beerenwinkel·bioRxiv·Apr 26, 2021
- Distinct functions of PBRM1 and BAP1 reconcile the course of kidney cancer evolution and disease progression
Daqi Deng, Hugang Feng, … Samra Turajlic·bioRxiv·May 3, 2026
- Origins and timing of emerging lesions in advanced renal cell carcinoma
A. Wallace, S. Porten, … M. Meng·bioRxiv·Jun 27, 2021
- Genomic and transcriptomic landscape of advanced renal cell cancer to individualize treatment strategy
K. de Joode, W. S. van de Geer, … A. A. M. van der Veldt·Scientific ReportsPeer-reviewed·Jul 3, 2023
- Optical Genome and Epigenome Mapping of Clear Cell Renal Cell Carcinoma
Sapir Margalit, Zuzana Tulpová, … Yuval Ebenstein·NAR CancerPeer-reviewed·Jan 15, 2025
- Convergent genomic and molecular features predict risk of metachronous metastasis in clear cell renal cell carcinoma
Marjan Mojtabavi Naeini, Mengyuan Pang, … Anders J. Skanderup·Communications MedicinePeer-reviewed·Feb 25, 2026